Evidence map›Paper›PMID 30847740›Full record

ArticleMolecular neurobiology2019

A Single Amino Acid Substitution, Found in Mammals with Low Susceptibility to Prion Diseases, Delays Propagation of Two Prion Strains in Highly Susceptible Transgenic Mouse Models.

Alicia Otero, Carlos Hedman, Natalia Fernández-Borges, Hasier Eraña, Belén Marín, Marta Monzón, Manuel A Sánchez-Martín, Romolo Nonno, Juan José Badiola, Rosa Bolea and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. The First Report of Polymorphisms and Genetic Features of theInternational journal of molecular sciences · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Alicia OteroCentro de Encefalopatías y Enfermedades Transmisibles Emergentes, Facultad de Veterinaria, IA2, IIS, Universidad de Zaragoza, Zaragoza, Spain.
Carlos HedmanCentro de Encefalopatías y Enfermedades Transmisibles Emergentes, Facultad de Veterinaria, IA2, IIS, Universidad de Zaragoza, Zaragoza, Spain.
Natalia Fernández-BorgesCIC bioGUNE, Parque Tecnológico de Bizkaia, Derio, Bizkaia, Spain.
Hasier ErañaCIC bioGUNE, Parque Tecnológico de Bizkaia, Derio, Bizkaia, Spain.
Belén MarínCentro de Encefalopatías y Enfermedades Transmisibles Emergentes, Facultad de Veterinaria, IA2, IIS, Universidad de Zaragoza, Zaragoza, Spain.
Marta MonzónCentro de Encefalopatías y Enfermedades Transmisibles Emergentes, Facultad de Veterinaria, IA2, IIS, Universidad de Zaragoza, Zaragoza, Spain.
Manuel A Sánchez-MartínServicio de Transgénesis, Nucleus, Universidad de Salamanca, Salamanca, Spain.
Romolo NonnoDepartment of Food Safety and Veterinary Public Health, Istituto Superiore di Sanità, Rome, Italy.
Juan José BadiolaCentro de Encefalopatías y Enfermedades Transmisibles Emergentes, Facultad de Veterinaria, IA2, IIS, Universidad de Zaragoza, Zaragoza, Spain.
Rosa BoleaCentro de Encefalopatías y Enfermedades Transmisibles Emergentes, Facultad de Veterinaria, IA2, IIS, Universidad de Zaragoza, Zaragoza, Spain. rbolea@unizar.es.
Joaquín CastillaCIC bioGUNE, Parque Tecnológico de Bizkaia, Derio, Bizkaia, Spain. castilla@joaquincastilla.com.ORCID http://orcid.org/0000-0002-2216-1361
Universidad de Zaragoza · ESCIC bioGUNE · ESIkerbasque · ESIstituto Superiore di Sanità · ITUniversidad de Salamanca · ES

Funding

Interreg POCTEFA POCTEFA EFA148/16Ministerio de Economía, Industria y Competitividad, Gobierno de España AGL2015-65046-C2-1-RMinisterio de Economía, Industria y Competitividad, Gobierno de España AGL2015-65560-R
6 · The paper itself

Abstract

Specific variations in the amino acid sequence of prion protein (PrP) are key determinants of susceptibility to prion diseases. We previously showed that an amino acid substitution specific to canids confers resistance to prion diseases when expressed in mice and demonstrated its dominant-negative protective effect against a variety of infectious prion strains of different origins and characteristics. Here, we show that expression of this single amino acid change significantly increases survival time in transgenic mice expressing bank vole cellular prion protein (PrP

Indexed as

Amino Acid SubstitutionAnimalsArvicolinaeDisease Models, AnimalDisease SusceptibilityMammalsMice, TransgenicPrion DiseasesPrionsSurvival AnalysisPrionsBank vole PrPCanine PrPPrion propagationPrionsTransmissible spongiform encephalopathies

Identifiers

PMID30847740
OpenAlexW2919165841

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.